Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
July 31, 2026 -158.7%
April 30, 2026 -93.92%
January 31, 2026 -94.52%
October 31, 2025 -78.05%
July 31, 2025 -129.3%
April 30, 2025 -125.1%
January 31, 2025 -804.7%
October 31, 2024 -132.4%
July 31, 2024 -170.3%
April 30, 2024 -272.6%
January 31, 2024 -43.06%
October 31, 2023 -39.17%
July 31, 2023 -60.06%
April 30, 2023 -91.25%
January 31, 2023 -90.87%
October 31, 2022 -141.8%
July 31, 2022 -200.1%
April 30, 2022 -88.64%
January 31, 2022 -79.46%
October 31, 2021 -106.1%
Date Value
July 31, 2021 -70.40%
April 30, 2021 -103.2%
January 31, 2021 -28.66%
October 31, 2020 -9.75%
July 31, 2020 -14.59%
April 30, 2020 -22.82%
January 31, 2020 -15.51%
October 31, 2019 -43.12%
July 31, 2019 -74.08%
April 30, 2019 -145.5%
January 31, 2019 -44.04%
October 31, 2018 -54.69%
July 31, 2018 -38.37%
April 30, 2018 -121.4%
January 31, 2018 -70.31%
October 31, 2017 -68.62%
July 31, 2017 -145.1%
April 30, 2017 -201.3%
January 31, 2017 -868.7%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Repligen Corp. 2.45%
Bio-Techne Corp. 17.01%
BioLife Solutions, Inc. --
Maravai Lifesciences Holdings, Inc. -42.05%
MaxCyte, Inc. -122.0%